Skip to content

Rafael Aldabe

  • PhD
  • University of Navarra
  • 13h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 709CitationsNumber of citations received by Rafael's publications. Updated daily.

Other IDs

Research interests

Rare diseasesGene therapyChimeric miceLiver zonationLiver regenerationMouse modelsAcetylationCell polarityActin cytoskeletonProtein Postranslational modifications

Co-authors (139)

Publications (5)

  • N-terminal acetylation modulates Bax targeting to mitochondria

    • Alves S
    • Neiri L
    • Chaves S
    • et al.
    N/AReaders
    1Citations
    Get full text
  • A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction

    • Suárez-Amarán L
    • Usai C
    • Di Scala M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma

    • Neri L
    • Lasa M
    • Elosegui-Artola A
    • et al.
    N/AReaders
    1Citations
    Get full text
  • Cold preservation of human adult hepatocytes for liver cell therapy

    • Duret C
    • Moreno D
    • Balasiddaiah A
    • et al.
    N/AReaders
    5Citations
    Get full text
  • N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB

    • Van Damme P
    • Lasa M
    • Polevoda B
    • et al.
    N/AReaders
    61Citations
    Get full text

Professional experience

Universidad de Navarra